|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：N379117 |
| 產(chǎn)品名稱：Narlaprevir-d4 |
| 產(chǎn)品CAS： |
| 規(guī)格含量：25mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
N379117 |
| 名稱: |
Narlaprevir-d4 |
| 別名: |
(1R,2S,5S)-N-[(1S)-1-[(Cyclopropylamino)oxoacetyl]pentyl]-3-[(2S)-2-[[[[1-[[(1,1-dimethylethyl)sulfonyl]methyl]cyclohexyl]amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-Azabicyclo[3.1.0]hexane-2-carboxamide-d4; |
| 參考CAS號(hào): |
Unlabelled: 865466-24-6 |
| 分子式: |
C??H??D?N?O?S |
| 分子量: |
711.99 |
| 種類: |
Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
Isotope labelled Narlaprevir is a drug used in the treatment of hepatitis C, an HCV NS3 serine protease inhibitor. |
| 參考文獻(xiàn) |
|
|
|
|
?您的位置：
